Akari Therapeutics (AKTX) Stock: Running Up On New Data
Akari Therapeutics PLC (NASDAQ: AKTX) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced positive data, exciting investors who are sending the stock for the top. Today, we’ll talk about: The clinical data; what we’re seeing from AKTX stock as a result; and what we’ll … Read more